These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31330295)

  • 1. Antifungal resistance in dermatophytes: Recent trends and therapeutic implications.
    Khurana A; Sardana K; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103255. PubMed ID: 31330295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy.
    Gaurav V; Bhattacharya SN; Sharma N; Datt S; Kumar P; Rai G; Singh PK; Taneja B; Das S
    J Mycol Med; 2021 Mar; 31(1):101087. PubMed ID: 33360137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation.
    Sardana K; Gupta A; Sadhasivam S; Gautam RK; Khurana A; Saini S; Gupta S; Ghosh S
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0032121. PubMed ID: 34097482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole in common dermatophyte infections of the skin: fixed treatment schedules.
    Saul A; Bonifaz A
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):554-8. PubMed ID: 2170473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistant tinea corporis/cruris: Response to voriconazole.
    Khurana A; Agarwal A; Agrawal D; Sardana K; Singh A; Chowdhary A
    J Mycol Med; 2022 Nov; 32(4):101306. PubMed ID: 35785725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Antifungal Agents and New Formulations Against Dermatophytes.
    Gupta AK; Foley KA; Versteeg SG
    Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
    Gupta AK; Einarson TR; Summerbell RC; Shear NH
    Drugs; 1998 May; 55(5):645-74. PubMed ID: 9585862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of
    Khurana A; Masih A; Chowdhary A; Sardana K; Borker S; Gupta A; Gautam RK; Sharma PK; Jain D
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclopirox for the treatment of superficial fungal infections: a review.
    Gupta AK; Skinner AR
    Int J Dermatol; 2003 Sep; 42 Suppl 1():3-9. PubMed ID: 12895181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
    Millikan LE
    Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and prophylaxis of tinea infections.
    Piérard GE; Arrese JE; Piérard-Franchimont C
    Drugs; 1996 Aug; 52(2):209-24. PubMed ID: 8841739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical therapy for dermatophytoses: should corticosteroids be included?
    Erbagci Z
    Am J Clin Dermatol; 2004; 5(6):375-84. PubMed ID: 15663334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral terbinafine: a new antifungal agent.
    Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1997 Apr; 31(4):445-56. PubMed ID: 9101008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center.
    Mahajan S; Tilak R; Kaushal SK; Mishra RN; Pandey SS
    Indian J Dermatol Venereol Leprol; 2017; 83(4):436-440. PubMed ID: 28540871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
    Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.
    Monk JP; Brogden RN
    Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review.
    Sahoo AK; Mahajan R
    Indian Dermatol Online J; 2016; 7(2):77-86. PubMed ID: 27057486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.